Founders & Board of directors

Pan Zheng, MD, PhD


Dr. Zheng co-founded OncoImmune, Inc. while she was a faculty at the Ohio State University.  Dr. Zheng is currently a Professor at the University of Maryland Baltimore, Institute of Human Virology, Division of Immunotherapy, where her lab focuses on the fields of hematopoietic stem cell study, immunology and cancer biology. Dr. Zheng was trained in anatomic and clinical pathology and is a Board-certified Physician with the American Board of Pathology. Dr. Zheng received her MD from Peking Union Medical College and PhD from Yale University. She had residency training at Peking Union Medical College Hospital in Beijing and in New York University Medical Center. She has been a faculty member at the Ohio State University, the University of Michigan, Children’s National Medical Center and George Washington University.

About Us

Based in Rockville, Maryland, OncoImmune is a
privately-held, clinical-stage biopharmaceutical
company that is actively engaged in the discovery
and development of biopharmaceuticals for the
treatment of cancer and autoimmune disease.

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.